Novo Nordisk (NVO) has released an update. Novo Nordisk has disclosed recent transactions involving the purchase of 1,300 American Depositary Receipts (ADRs) by its board members and executives. This ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk, whose profits from blockbuster weight-loss ...
Novo Nordisk (NVO) has released an update. Novo Nordisk has announced recent transactions involving its shares by board members and executives, highlighting an acquisition of 18,634 shares and a sale ...
Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...
All doses of Novo Nordisk's weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the FDA's drug shortage database. It is a sign that Novo ...
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Novo Nordisk A/S and RTX Corp., as well as a micro-cap stock FONAR Corp. The Zacks microcap research ...
As if there weren't enough reasons to buy shares of the cardiometabolic drug juggernauts Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), there's now one more big reason to expect these two ...
The Danish drug company Novo Nordisk has been sanctioned by the UK pharmaceutical industry regulator over the way it has promoted its weight loss medications semaglutide (Ozempic/Wegovy) and ...
The Los Angeles Rams and cornerback Tre'Davious White are speaking about the player's future, including the possibility of a deal before the Nov. 5 trade deadline, according to ESPN's Jeremy Fowler.
This marks Novo Nordisk's second win this year in treating cardiovascular disease. The company develops a long line of blockbuster glucagon-like peptide-1 (GLP-1) agonists, including Ozempic ...